Literature DB >> 12403069

MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling.

Toshiyuki Sakaeda1, Tsutomu Nakamura, Midori Hirai, Takashi Kimura, Atsushi Wada, Tatsurou Yagami, Hironao Kobayashi, Shunji Nagata, Noboru Okamura, Takayoshi Yoshikawa, Toshiro Shirakawa, Akinobu Gotoh, Masafumi Matsuo, Katsuhiko Okumura.   

Abstract

PURPOSE: Recently, MDR1 (P-glycoprotein) and related transporters have been suggested to play a fundamental role in regulating apoptosis, but little information is available concerning the role of MDR1. Here, the effect of apoptotic stimuli on the MDR1 mRNA and apoptotic signaling was examined in MDR1-overexpressing cells.
METHODS: The expression levels of mRNA for MDR1, MRP1, MRP2, p53, p21, Bax, and Bcl-2 were measured by real time quantitative polymerase chain reaction in HeLa and its MDR1-overexpressing sublines. The effects of apoptotic stimuli by cisplatin (CDDP) on their levels were also assessed as well as on caspase 3, 8, and 9 activities.
RESULTS: MDR1 was rapidly upregulated when the cells were exposed to apoptotic stimuli by CDDP. The increase in Bax mRNA to Bcl-2 mRNA ratio after treatment with CDDP was suppressed in MDR1-overexpressing cells. The increases in caspase 3 and 9 activities after treatment with CDDP were suppressed in MDR1-overexpression cells.
CONCLUSION: MDR1 is upregulated by apoptotic stimuli suppressed apoptotic signaling presumably via the mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403069     DOI: 10.1023/a:1020302825511

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells.

Authors:  N Iida; K Takara; N Ohmoto; T Nakamura; T Kimura; A Wada; M Hirai; T Sakaeda; K Okumura
Journal:  Biol Pharm Bull       Date:  2001-09       Impact factor: 2.233

3.  Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.

Authors:  A S Chong; P N Markham; H M Gebel; S D Bines; J S Coon
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

Authors:  G Raghu; S W Park; I B Roninson; E B Mechetner
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

5.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 6.  A role for P-glycoprotein in regulating cell death.

Authors:  R W Johnstone; A A Ruefli; K M Tainton; M J Smyth
Journal:  Leuk Lymphoma       Date:  2000-06

Review 7.  Cancer chemoresistance: the relationship between p53 and multidrug transporters.

Authors:  Jason A Bush; Gang Li
Journal:  Int J Cancer       Date:  2002-03-20       Impact factor: 7.396

Review 8.  Multidrug resistance in human tumors--molecular diagnosis and clinical significance.

Authors:  C Ramachandran; S J Melnick
Journal:  Mol Diagn       Date:  1999-06

9.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

Authors:  G J Randolph; S Beaulieu; M Pope; I Sugawara; L Hoffman; R M Steinman; W A Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  P-glycoprotein expression and function in circulating blood cells from normal volunteers.

Authors:  W T Klimecki; B W Futscher; T M Grogan; W S Dalton
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

View more
  9 in total

1.  Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.

Authors:  Hairong Huo; Pellegrino G Magro; E Christy Pietsch; Brijesh B Patel; Kathleen W Scotto
Journal:  Cancer Res       Date:  2010-09-22       Impact factor: 12.701

2.  Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas.

Authors:  Takako Nakahara; Toshiyuki Sakaeda; Tsutomu Nakamura; Takao Tamura; Chiharu Nishioka; Nobuo Aoyama; Noboru Okamura; Toshiro Shirakawa; Akinobu Gotoh; Takashi Kamigaki; Masakazu Ohno; Yoshikazu Kuroda; Masafumi Matsuo; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

3.  VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.

Authors:  Motohiro Yamamori; Mayuko Taniguchi; Shingo Maeda; Tsutomu Nakamura; Noboru Okamura; Akiko Kuwahara; Koichi Iwaki; Takao Tamura; Nobuo Aoyama; Svetlana Markova; Masato Kasuga; Katsuhiko Okumura; Toshiyuki Sakaeda
Journal:  Int J Med Sci       Date:  2008-04-08       Impact factor: 3.738

4.  Curcumin prevents induced drug resistance: a novel function?

Authors:  Dong Xu; Wei Tian; Hong Shen
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

5.  Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization.

Authors:  Alberto Javier Ramos; Alberto Lazarowski; Marcelo J Villar; Alicia Brusco
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

6.  AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells.

Authors:  L Harhaji-Trajkovic; U Vilimanovich; T Kravic-Stevovic; V Bumbasirevic; V Trajkovic
Journal:  J Cell Mol Med       Date:  2009-09       Impact factor: 5.310

Review 7.  Molecular mechanisms of cisplatin resistance in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Wenwen Zhang; Zhaojun Shen; Xiaoli Hu; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2016-06-07       Impact factor: 4.162

8.  Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.

Authors:  Yanxia Sui; Ya Yang; Ji Wang; Yi Li; Hongbing Ma; Hui Cai; Xiaoping Liu; Yong Zhang; Shufeng Wang; Zongfang Li; Xiaozhi Zhang; Jiansheng Wang; Rui Liu; Yanli Yan; Chaofan Xue; Xiaowei Shi; Li Tan; Juan Ren
Journal:  Biomed Res Int       Date:  2015-08-20       Impact factor: 3.411

9.  OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.

Authors:  Xiao Zhi; Wei Chen; Fei Xue; Chao Liang; Bryan Wei Chen; Yue Zhou; Liang Wen; Liqiang Hu; Jian Shen; Xueli Bai; Tingbo Liang
Journal:  Oncotarget       Date:  2015-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.